Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
about
ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice.GUCY2C maintains intestinal LGR5+ stem cells by opposing ER stress.Cyclic-GMP-Elevating Agents Suppress Polyposis in ApcMin mice by Targeting the Preneoplastic Epithelium.Phosphodiesterase-5 inhibitors for colon cancer chemopreventionThe Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia
P2860
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
@en
type
label
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
@en
prefLabel
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
@en
P2093
P2860
P1476
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
@en
P2093
David M Kastenberg
David S Weinberg
Drew Seisler
Gary Della'Zanna
Jieru E Lin
Leo C Katz
Nathan R Foster
Paul J Limburg
Walter K Kraft
P2860
P304
P356
10.1158/1940-6207.CAPR-16-0286
P577
2017-04-10T00:00:00Z